133 related articles for article (PubMed ID: 17168441)
21. [Current TNM system of the UICC/AJCC : the prognostic significance for differentiated thyroid carcinoma].
Stratmann M; Sekulla C; Dralle H; Brauckhoff M
Chirurg; 2012 Jul; 83(7):646-51. PubMed ID: 22273853
[TBL] [Abstract][Full Text] [Related]
22. Insular carcinoma: an infrequent subtype of thyroid cancer.
Rodriguez JM; Parrilla P; Moreno A; Sola J; Pinero A; Ortiz S; Soria T
J Am Coll Surg; 1998 Nov; 187(5):503-8. PubMed ID: 9809566
[TBL] [Abstract][Full Text] [Related]
23. Well-differentiated thyroid carcinomas: p53 mutation status and microvessel density.
Goldenberg JD; Portugal LG; Wenig BL; Ferrer K; Wu JC; Sabnani J
Head Neck; 1998 Mar; 20(2):152-8. PubMed ID: 9484947
[TBL] [Abstract][Full Text] [Related]
24. Poorly differentiated carcinoma of the thyroid. A clinicopathologic entity for a high-risk group of papillary and follicular carcinomas.
Sakamoto A; Kasai N; Sugano H
Cancer; 1983 Nov; 52(10):1849-55. PubMed ID: 6313176
[TBL] [Abstract][Full Text] [Related]
25. Cytologic features of poorly differentiated "insular" carcinoma of the thyroid. A case report.
Zakowski MF; Schlesinger K; Mizrachi HH
Acta Cytol; 1992; 36(4):523-6. PubMed ID: 1636346
[TBL] [Abstract][Full Text] [Related]
26. Cyclin D1 in well differentiated thyroid tumour of uncertain malignant potential.
Lamba Saini M; Weynand B; Rahier J; Mourad M; Hamoir M; Marbaix E
Diagn Pathol; 2015 Apr; 10():32. PubMed ID: 25907675
[TBL] [Abstract][Full Text] [Related]
27. Fine-needle aspiration of an unusual case of poorly differentiated insular carcinoma of the thyroid.
Gong Y; Krishnamurthy S
Diagn Cytopathol; 2005 Feb; 32(2):103-7. PubMed ID: 15637672
[TBL] [Abstract][Full Text] [Related]
28. Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer.
Mazzaferri EL; Jhiang SM
Am J Med; 1994 Nov; 97(5):418-28. PubMed ID: 7977430
[TBL] [Abstract][Full Text] [Related]
29. Long-term outcome of patients with insular carcinoma of the thyroid: the insular histotype is an independent predictor of poor prognosis.
Pellegriti G; Giuffrida D; Scollo C; Vigneri R; Regalbuto C; Squatrito S; Belfiore A
Cancer; 2002 Nov; 95(10):2076-85. PubMed ID: 12412160
[TBL] [Abstract][Full Text] [Related]
30. Extremely Well-Differentiated Papillary Thyroid Carcinoma Resembling Adenomatous Hyperplasia Can Metastasize to the Skull: A Case Report.
Pyo JY; Kim J; Choi SE; Shin E; Yang SW; Park CS; Kim SM; Hong S
Yonsei Med J; 2017 Jan; 58(1):255-258. PubMed ID: 27873522
[TBL] [Abstract][Full Text] [Related]
31. Overview of the 2022 WHO Classification of Thyroid Neoplasms.
Baloch ZW; Asa SL; Barletta JA; Ghossein RA; Juhlin CC; Jung CK; LiVolsi VA; Papotti MG; Sobrinho-Simões M; Tallini G; Mete O
Endocr Pathol; 2022 Mar; 33(1):27-63. PubMed ID: 35288841
[TBL] [Abstract][Full Text] [Related]
32. Poorly differentiated ("insular") carcinoma of the thyroid gland: an aggressive subset of differentiated thyroid neoplasms.
Flynn SD; Forman BH; Stewart AF; Kinder BK
Surgery; 1988 Dec; 104(6):963-70. PubMed ID: 3194848
[TBL] [Abstract][Full Text] [Related]
33. Insular thyroid carcinoma: a retrospective clinicopathologic study.
Hod R; Bachar G; Sternov Y; Shvero J
Am J Otolaryngol; 2013; 34(4):292-5. PubMed ID: 23357591
[TBL] [Abstract][Full Text] [Related]
34. RET/PTC oncogene activation defines a subset of papillary thyroid carcinomas lacking evidence of progression to poorly differentiated or undifferentiated tumor phenotypes.
Tallini G; Santoro M; Helie M; Carlomagno F; Salvatore G; Chiappetta G; Carcangiu ML; Fusco A
Clin Cancer Res; 1998 Feb; 4(2):287-94. PubMed ID: 9516913
[TBL] [Abstract][Full Text] [Related]
35. Bcl-2 and p53 expression in insular and in well-differentiated thyroid carcinomas with an insular pattern.
Peştereli HE; Oğüş M; Oren N; Karpuzoğlu G; Kerpuzoğlu T
Endocr Pathol; 2001; 12(3):301-5. PubMed ID: 11740051
[TBL] [Abstract][Full Text] [Related]
36. [Therapy concept in differentiated thyroid gland carcinoma--results of 25 years with 257 patients].
Gemsenjäger E; Heitz PU; Martina B; Schweizer I
Praxis (Bern 1994); 2000 Nov; 89(44):1779-97. PubMed ID: 11109916
[TBL] [Abstract][Full Text] [Related]
37. Progression of Papillary Thyroid Carcinoma to Anaplastic Carcinoma in Metastatic Lymph Nodes: Solid/Insular Growth and Hobnail Cell Change in Lymph Nodes Are Predictors of Subsequent Anaplastic Transformation.
Odate T; Oishi N; Kawai M; Tahara I; Mochizuki K; Akaishi J; Ito K; Katoh R; Kondo T
Endocr Pathol; 2021 Sep; 32(3):347-356. PubMed ID: 33761111
[TBL] [Abstract][Full Text] [Related]
38. Cribriform-morular variant of papillary thyroid carcinoma displaying poorly differentiated features.
Nakazawa T; Celestino R; Machado JC; Cameselle-Teijeiro JM; Vinagre J; Eloy C; Benserai F; Lameche S; Soares P; Sobrinho-Simões M
Int J Surg Pathol; 2013 Aug; 21(4):379-89. PubMed ID: 23349472
[TBL] [Abstract][Full Text] [Related]
39. [Insular carcinoma of the thyroid. An uncommon but aggressive neoplasm].
Naranjo-Gómez JM; Folqué-Gómez E; Moreno-Mata N; Moldes-Rodríguez M; Martínez-Martínez P; González-Aragoneses F; Orusco-Palomino E
Cir Esp; 2005 Apr; 77(4):236-9. PubMed ID: 16420925
[TBL] [Abstract][Full Text] [Related]
40. Clinical features of poorly differentiated thyroid papillary carcinoma.
Higashino M; Ayani Y; Terada T; Kurisu Y; Hirose Y; Kawata R
Auris Nasus Larynx; 2019 Jun; 46(3):437-442. PubMed ID: 30466760
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
